Sign in

CIK 0001563880

  • Non-accelerated filer
  • Smaller reporting company

Trevi Therapeutics, Inc.

Sign in to watch
Ticker
TRVI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
450834299
Phone
+1 203-304-2499
Business address
195 CHURCH STREET, 16TH FLOOR, NEW HAVEN, CT, 06510
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$595,806
in 1 filing, $596K under 10b5-1 plans

Net −$595,806. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Heffernan Michael Thomas −$596K Director sold 86% of stake

Reading 6 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-05-09 Richard King Mellon Foundation 10% owner Other acquisition +24,341 247,157
2019-05-09 Richard King Mellon Foundation 10% owner Purchase +100,000 $10.00 $1.0M 347,157
2019-05-09 Richard King Mellon Foundation 10% owner Conversion · Series C Preferred Stock −1,908,450 0
2019-05-09 VANLENT ANNE Director Conversion +20,983 20,983
2019-05-09 VANLENT ANNE Director Purchase +5,000 $10.00 $50K 25,983
2019-05-09 VANLENT ANNE Director Conversion · Series A Preferred Stock −107,977 0
2019-05-09 VANLENT ANNE Director Conversion · Series C Preferred Stock −47,807 0
2019-05-09 Lundbeckfond Invest A/S 10% owner Conversion +776,544 776,544
2019-05-09 Lundbeckfond Invest A/S 10% owner Purchase +375,000 $10.00 $3.8M 1,151,544
2019-05-09 Lundbeckfond Invest A/S 10% owner Conversion · Series C Preferred Stock −6,849,315 0
2019-05-09 Drake Debra A 10% owner Conversion +52,141 52,141
2019-05-09 Drake Debra A 10% owner Conversion +10,399 10,399
2019-05-09 Drake Debra A 10% owner Conversion · Series A Preferred Stock −58,153 0
2019-05-09 Drake Debra A 10% owner Conversion · Series A Preferred Stock −75,000 0
2019-05-09 Drake Debra A 10% owner Conversion · Series C Preferred Stock −376,023 0
2019-05-09 SCIASCIA THOMAS Chief Medical Officer Conversion +17,118 193,724
2019-05-09 SCIASCIA THOMAS Chief Medical Officer Conversion · Series A Preferred Stock −109,015 0
2019-05-09 SCIASCIA THOMAS Chief Medical Officer Conversion · Series C Preferred Stock −13,410 0
2019-05-07 Mathers Edward T Director Grant or award · Stock Option (right to buy) +23,684 23,684

Page 21 of 21 · 419 trades